Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Intellipharmaceutics International Inc.

NASDAQ: IPCIHealthcare / Drug Delivery / Canada
0.23-0.03-11.54%Vol 897 7991Y Perf -97.00%
Dec 10th, 2018 14:00
BID0.23 ASK0.24
Open0.27 Previous Close0.27
Pre-Market- After-Trading-
 - -%  - -%
Target Price
27.50 
Analyst Rating
Moderate Buy 2.33
Potencial %
10 900.00 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★+     38.38
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)2 
Earnings Rating
Neutral
Price Range Ratio 52wk %
0.00 
Earnings Date
27th Nov 2018

Today's Price Range

0.230.27

 

52wk Range

0.2310.50

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Month
-50.94%
3 Months
-36.59%
6 Months
-38.10%
1 Year
-97.00%
3 Years
-88.02%
5 Years
-92.26%

Quotes

Name / TickerPriceChg.Chg.%
IPCI0.23-0.0300-11.54
AAPL169.110.62000.37
GOOG1 040.013.43000.33
MSFT106.281.46001.39
XOM76.00-1.6400-2.11
WFC48.74-1.5200-3.02
JNJ144.50-0.9300-0.64
FB140.893.47002.53
GE6.93-0.0800-1.14
JPM101.32-1.9700-1.91
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
0.10
Current Ratio
0.20
Long Term Debt to Total Capital
-
Total Debt to Equity
3.34
Interest Coverage
-31.30
Leverage Ratio -2.00
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
90.50
EBIT Margin
-503.10
EBITDA Margin
-476.60
Pre-tax Profit Margin
-199.80
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
62.79
PS Ratios
1.84
Price to Cash Flow
-
Price to Free Cash Flow
-0.40
Cash Flow Per Share
-2.95
Price to Tangible Book
-0.50
Book Value per Share
-0.70
Enterprise Value (in ths.)
3 199
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
123 469.00
ROE last 12 Months
435.21
Return on Assets (5Y Avg)
-136.51
ROA last 12 Months
-205.68
Return on Capital (5Y Avg)
-293.63
ROC last 12 Months
-189.03
Return on invested Capital Q
-189.03
Return on invested Capital Y
-387.94
Assets Turnover
0.20
Receivables Turnover
1.10
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
2 321
Revenue per Share
0.18
Revenue Growth 3 Years
-18.14
Revenue Growth 5 Years
3.26
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018--0.91-
Q02 2018-0.70-0.700.00
Q01 2018-0.50-0.90-80.00
Q04 2017-0.70-0.80-14.29
Q03 2017-0.40-0.80-100.00
Q02 2017-0.50-0.60-20.00
Q01 2017-0.08-0.0712.50
Q04 2016-0.06-0.14-133.33
Earnings Per EndEstimateRevision %Trend
8/2018 QR-0.400.00-
11/2018 QR0.00--
11/2018 FY-1.950.00-
11/2019 FY-1.000.00-
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume897 799
Shares Outstanding (in ths.)9 620
Trades Count1 115
Dollar Volume231 510
Avg. Volume304 602
Avg. Weekly Volume1 064 481
Avg. Monthly Volume2 446 460
Avg. Quarterly Volume1 068 419

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

44%56%

Bearish Bullish

40%60%

Bearish Bullish

74%26%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (33.33 %)
2 (66.67 %)
2 (66.67 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (66.67 %)
1 (33.33 %)
1 (33.33 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
2.33
Moderate Buy
1.67
Moderate Buy
1.67

There are no comments yet.

News